Skip to content

Incidence and Nature of Heparin-induced Skin Lesions in Medical Patients

Inzidenz Und Art Heparin-induzierter Hautveränderungen

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00510432
Enrollment
500
Registered
2007-08-02
Start date
2007-04-30
Completion date
2009-01-31
Last updated
2009-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergy

Keywords

heparin, heparin-induced thrombocytopenia, HIT, allergy, skin, dermatology, DTH, delayed-type hypersensitivity, histology, Patients receiving sc heparin therapy, Age over 18 years, Recruitment will stop when 20 patients with skin lesions are included

Brief summary

An increased number of patients with heparin-induced skin lesions is reported in the literature. Heparin-induced skin lesions may result from either occlusion of cutaneous vessels in patients suffering from autoimmune HIT or from a type IV allergic reaction (delayed type hypersensitivity (DTH) response). However, the incidence and nature of heparin-induced skin lesions has not been determined in a prospective investigation. To address this open issue is the goal of this ongoing, so far monocenter, clinical investigation.

Interventions

None listed

Sponsors

Johann Wolfgang Goethe University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age \> 18 Y. * s.c. anticoagulant therapy \>6 days

Exclusion criteria

* history of HIT * history of DTH to heparin

Countries

Germany

Contacts

Primary ContactRalf J Ludwig, MD
r.ludwig@em.uni-frankfurt.de+49-69-6301-
Backup ContactWolf-Henning Boehncke, Professor
boehncke@em.uni-frankfurt.de+49-69-6301-

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 30, 2026